γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
NCT07123662
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Leukemia
Myeloid
Acute
Interventions
BIOLOGICAL:
Gamma-Delta T cell injection
OTHER:
Standard prophylactic treatment
Sponsor
Guangzhou Bio-gene Technology Co., Ltd